FY2019 EPS Estimates for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Lifted by Cantor Fitzgerald

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Equities researchers at Cantor Fitzgerald upped their FY2019 EPS estimates for shares of Allscripts Healthcare Solutions in a note issued to investors on Tuesday, November 5th. Cantor Fitzgerald analyst S. Halper now expects that the software maker will post earnings per share of $0.49 for the year, up from their prior forecast of $0.47. Cantor Fitzgerald currently has a “Neutral” rating on the stock. Cantor Fitzgerald also issued estimates for Allscripts Healthcare Solutions’ FY2020 earnings at $0.53 EPS.

Several other equities research analysts have also recently commented on the company. Robert W. Baird set a $13.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Monday, August 12th. Deutsche Bank initiated coverage on Allscripts Healthcare Solutions in a research note on Thursday, September 26th. They set a “hold” rating and a $11.00 price target for the company. Jefferies Financial Group initiated coverage on Allscripts Healthcare Solutions in a research note on Friday, August 23rd. They set a “buy” rating and a $13.00 price target for the company. BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Tuesday, September 24th. Finally, ValuEngine cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $11.75.

Allscripts Healthcare Solutions stock opened at $11.18 on Friday. Allscripts Healthcare Solutions has a 12 month low of $8.54 and a 12 month high of $12.40. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.66 and a quick ratio of 0.91. The business has a 50 day simple moving average of $10.84 and a 200-day simple moving average of $10.40. The stock has a market capitalization of $1.89 billion, a PE ratio of 20.33, a price-to-earnings-growth ratio of 2.62 and a beta of 1.39.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Monday, November 4th. The software maker reported $0.17 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.17. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. The business had revenue of $445.00 million during the quarter, compared to analysts’ expectations of $450.04 million. During the same quarter in the prior year, the business earned $0.18 earnings per share. The company’s quarterly revenue was up 2.9% compared to the same quarter last year.

A number of hedge funds have recently made changes to their positions in the stock. Tamarack Advisers LP grew its holdings in Allscripts Healthcare Solutions by 7.6% during the third quarter. Tamarack Advisers LP now owns 4,225,000 shares of the software maker’s stock worth $46,391,000 after acquiring an additional 300,000 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Allscripts Healthcare Solutions by 12.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 35,461 shares of the software maker’s stock worth $389,000 after acquiring an additional 3,958 shares during the period. Boston Advisors LLC grew its holdings in Allscripts Healthcare Solutions by 42.9% during the third quarter. Boston Advisors LLC now owns 153,978 shares of the software maker’s stock worth $1,691,000 after acquiring an additional 46,232 shares during the period. Tibra Equities Europe Ltd acquired a new position in Allscripts Healthcare Solutions during the third quarter worth $324,000. Finally, Russell Investments Group Ltd. grew its holdings in Allscripts Healthcare Solutions by 0.3% during the third quarter. Russell Investments Group Ltd. now owns 1,084,615 shares of the software maker’s stock worth $11,872,000 after acquiring an additional 2,976 shares during the period.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Recommended Story: What are earnings reports?

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.